Improving Antihypertensive Agent Selection to Promote Nephroprotection

E-ISSN： 1875-6506|1|2|141-157

ISSN： 1573-4021

Source： Current Hypertension Reviews, Vol.1, Iss.2, 2005-06, pp. : 141-157

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The general practitioner and the preferable antihypertensive agent

By Werkö Lars

Scandinavian Cardiovascular Journal, Vol. 37, Iss. 2, 2003-01 ,pp. : 67-68

Informa Healthcare

Access to resources Recommend Favorite

A New Antihypertensive Agent that Antagonizes the Prohypertensive Effect of Endogenous Ouabain and Adducin

Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents), Vol. 4, Iss. 1, 2006-01 ,pp. : 61-66

Bentham Science Publishers

Access to resources Recommend Favorite

Improving Antihypertensive Efficacy while Maintaining Placebo-like Tolerability

By SEVER PETER S.

Blood Pressure, Vol. 9, Iss. 1, 2000-05 ,pp. : 19-22

Informa Healthcare

Access to resources Recommend Favorite

Improving Patient Selection for Clinical Acute Stroke Trials

Cerebrovascular Diseases, Vol. 21, Iss. 5-6, 2006-05 ,pp. : 386-392

Karger

Access to resources Recommend Favorite

Editorial [Hot Topic: New Concepts of Angiotensin Receptor Blocker (ARB) in Atherosclerosis: ARB as a Metabolic-Improving Agent (Guest Editor: Minako Yamaoka-Tojo)]

Current Vascular Pharmacology, Vol. 9, Iss. 2, 2011-03 ,pp. : 128-128

Bentham Science Publishers

Access to resources Recommend Favorite